Motilal Oswal recommends buying KEI Industries and Ipca Laboratories due to strong growth projections and strategic expansion. KEI shows 19% upside potential, with robust retail growth and innovations. Ipca targets a 21% increase with its US market expansion. Goldman Sachs maintains a "Buy" on UltraTech Cement, predicting a 9% rise, driven by demand growth and cost strategies.
